Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.
Read original at benzingaStocks · News reference
Medpace Holdings Q2 New Business Awards $795.7M Up 28.2% YoY; Resulted In Net Book-To-Bill Ratio Of 1.13x
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 22, 2026, 9:04 PM
- Checked
- Jul 22, 2026, 9:04 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $400 to $600.
Read original at benzingaTruist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $609
Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $462 to $609.
Read original at benzingaRBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
Read original at benzinga